Nifty

:

14342.00

Sensex

:

47956.18

-492.85 (-3.32%)
-1635.14 (-3.30%)

Login

Nifty
Sensex

:
:

14342.00
47956.18

-492.85 (-3.32%)
-1635.14 (-3.30%)

Krebs Biochemicals & Industries Ltd.

Pharmaceuticals & Drugs

Rating :

57/99

BSE: 524518 | NSE: KREBSBIO

Watchlist

NSE BSE

114.05

09-Apr-2021

Open
High
Low
Previous Close

120.00
120.00
112.00
121.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

70001
81.13
148.80
64.40

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

246.11
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

312.15
N/A
-10.51

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-7.45
91.72
-0.37

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
8.40
19.87

PAT CAGR (%)

10 Years
5 Years
3 Years

15.76
12.08
17.45

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-7.47
-7.47
-7.47

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-7.89
-22.37
-23.35

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 9.58 7.55 26.89% 16.69 6.45 158.76% 11.57 4.66 148.28% 14.75 11.71 25.96%
Expenses 15.23 12.00 26.92% 19.79 11.59 70.75% 15.87 9.67 64.12% 18.79 14.10 33.26%
EBITDA -5.65 -4.45 - -3.10 -5.13 - -4.30 -5.01 - -4.03 -2.39 -
EBIDTM -59.00% -59.00% -18.57% -79.54% -37.19% -107.53% -27.34% -20.39%
Other Income 0.06 0.02 200.00% 0.07 0.07 0.00% 0.05 0.18 -72.22% 0.10 0.16 -37.50%
Interest 1.43 1.70 -15.88% 2.13 1.63 30.67% 1.23 1.61 -23.60% 0.99 1.90 -47.89%
Depreciation 1.24 1.15 7.83% 1.24 1.15 7.83% 1.24 1.15 7.83% 1.23 1.18 4.24%
PBT -8.26 -7.28 - -6.39 -7.85 - -6.72 -7.59 - -6.16 -5.19 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -8.26 -7.28 - -6.39 -7.85 - -6.72 -7.59 - -6.16 -5.19 -
PATM -86.25% -96.49% -38.28% -121.60% -58.09% -162.81% -41.73% -44.35%
EPS -4.21 -3.71 - -3.26 -4.00 - -3.43 -3.87 - -3.14 -2.65 -

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11
Net Sales 52.59 33.41 47.76 33.78 3.53 1.29 0.00 0.00 11.45 70.76 72.44 Net Sales Growth 73.16% -30.05% 41.39% 856.94% 173.64% 0 0 -100% -83.82% -2.32% Cost Of Goods Sold 23.06 15.86 23.10 12.67 1.20 0.14 0.00 0.00 4.61 38.70 40.69 Gross Profit 29.53 17.55 24.65 21.10 2.33 1.14 0.00 0.00 6.83 32.06 31.76 GP Margin 56.16% 52.53% 51.61% 62.46% 66.01% 88.37% 0 0 59.65% 45.31% 43.84% Total Expenditure 69.68 51.97 57.52 41.28 11.53 13.69 4.90 4.04 24.63 74.54 72.24 Power & Fuel Cost - 10.28 11.70 8.62 0.70 2.87 0.28 1.87 6.24 18.79 12.99 % Of Sales - 30.77% 24.50% 25.52% 19.83% 222.48% 0 0 54.50% 26.55% 17.93% Employee Cost - 14.56 14.41 11.49 5.63 5.67 1.86 0.55 9.08 8.77 8.28 % Of Sales - 43.58% 30.17% 34.01% 159.49% 439.53% 0 0 79.30% 12.39% 11.43% Manufacturing Exp. - 6.77 4.09 4.59 1.07 1.62 0.62 0.04 1.76 3.57 4.27 % Of Sales - 20.26% 8.56% 13.59% 30.31% 125.58% 0 0 15.37% 5.05% 5.89% General & Admin Exp. - 4.05 4.05 3.76 2.88 3.33 2.14 1.54 2.57 2.36 2.46 % Of Sales - 12.12% 8.48% 11.13% 81.59% 258.14% 0 0 22.45% 3.34% 3.40% Selling & Distn. Exp. - 0.16 0.13 0.13 0.05 0.04 0.00 0.01 0.29 2.31 2.42 % Of Sales - 0.48% 0.27% 0.38% 1.42% 3.10% 0 0 2.53% 3.26% 3.34% Miscellaneous Exp. - 0.28 0.02 0.02 0.01 0.02 0.00 0.03 0.06 0.04 2.42 % Of Sales - 0.84% 0.04% 0.06% 0.28% 1.55% 0 0 0.52% 0.06% 1.53% EBITDA -17.08 -18.56 -9.76 -7.50 -8.00 -12.40 -4.90 -4.04 -13.18 -3.78 0.20 EBITDA Margin -32.48% -55.55% -20.44% -22.20% -226.63% -961.24% 0 0 -115.11% -5.34% 0.28% Other Income 0.28 0.37 0.33 0.21 0.08 1.03 0.01 0.18 6.14 2.75 7.02 Interest 5.78 6.00 6.29 5.17 3.49 0.74 4.03 0.08 0.63 8.66 7.52 Depreciation 4.95 4.68 4.40 4.15 4.23 4.49 1.87 0.00 8.28 9.66 9.60 PBT -27.53 -28.87 -20.12 -16.61 -15.65 -16.60 -10.79 -3.95 -15.94 -19.34 -9.89 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 -0.74 -1.90 -3.21 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -10.13% 4.64% 9.82% 32.46% PAT -27.53 -28.87 -20.01 -17.82 -16.05 -16.32 -7.84 -4.35 -15.20 -17.44 -6.68 PAT before Minority Interest -27.53 -28.87 -20.01 -17.82 -16.05 -16.32 -7.84 -4.35 -15.20 -17.44 -6.68 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -52.35% -86.41% -41.90% -52.75% -454.67% -1265.12% 0 0 -132.75% -24.65% -9.22% PAT Growth 0.00% - - - - - - - - - EPS -14.05 -14.73 -10.21 -9.09 -8.19 -8.33 -4.00 -2.22 -7.76 -8.90 -3.41

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11
Shareholder's Funds -25.00 -14.29 -17.78 1.48 13.01 18.28 3.60 7.95 23.15 40.59 Share Capital 18.00 16.63 13.74 13.74 13.06 9.51 9.51 9.51 9.51 9.05 Total Reserves -50.65 -30.92 -31.52 -12.27 -3.72 -14.08 -5.91 -1.57 13.64 30.24 Non-Current Liabilities 115.66 101.79 101.37 88.88 73.88 60.12 23.02 57.33 65.53 73.31 Secured Loans 0.00 0.00 1.89 5.03 21.40 14.00 15.00 48.70 59.09 64.94 Unsecured Loans 65.51 50.23 49.78 37.76 3.91 43.61 7.32 8.35 5.67 5.91 Long Term Provisions 2.46 4.04 3.68 2.82 3.57 3.83 2.02 2.00 1.74 1.53 Current Liabilities 43.13 54.86 42.28 31.72 29.52 28.72 109.84 70.64 58.93 42.91 Trade Payables 22.69 21.44 17.76 10.99 12.37 16.54 19.79 19.75 27.34 20.98 Other Current Liabilities 18.46 32.00 23.27 19.86 16.34 12.09 84.67 31.92 16.26 6.48 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 3.48 18.73 15.17 15.13 Short Term Provisions 1.99 1.43 1.25 0.87 0.82 0.09 1.90 0.24 0.16 0.33 Total Liabilities 133.79 142.36 125.87 122.08 116.41 107.12 136.46 135.92 147.61 156.81 Net Block 105.29 101.27 100.77 102.17 93.10 50.98 50.58 50.63 58.47 66.14 Gross Block 243.11 234.41 229.51 226.55 213.24 166.84 164.25 164.31 163.87 161.88 Accumulated Depreciation 137.82 133.15 128.74 124.38 120.14 115.86 113.66 113.67 105.40 95.74 Non Current Assets 114.94 111.39 108.64 109.10 107.03 92.26 97.66 97.49 104.59 108.58 Capital Work in Progress 4.19 3.48 3.73 3.50 10.54 7.46 7.13 7.13 6.96 5.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 5.24 6.22 3.72 3.23 3.19 33.82 39.95 39.73 39.16 37.45 Other Non Current Assets 0.22 0.42 0.41 0.20 0.20 0.00 0.00 0.00 0.00 0.00 Current Assets 18.86 30.98 17.24 12.97 9.39 14.87 38.81 38.43 43.02 48.23 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 15.00 8.96 11.73 5.45 5.64 5.45 30.82 30.82 30.49 29.40 Sundry Debtors 0.20 2.91 0.32 1.59 0.03 0.37 0.62 0.92 7.74 13.39 Cash & Bank 0.17 17.32 0.42 0.12 0.27 6.31 0.36 0.33 0.43 0.37 Other Current Assets 3.49 0.21 0.33 0.14 3.46 2.74 7.01 6.35 4.36 5.08 Short Term Loans & Adv. 3.18 1.57 4.44 5.67 3.38 0.59 5.41 4.91 2.88 4.15 Net Current Assets -24.27 -23.88 -25.04 -18.74 -20.14 -13.86 -71.03 -32.21 -15.92 5.32 Total Assets 133.80 142.37 125.88 122.07 116.42 107.13 136.47 135.92 147.61 156.81

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11
Cash From Operating Activity -35.86 3.90 -6.19 -11.20 -15.26 -45.26 49.24 -1.55 7.32 -4.62 PBT -28.87 -20.12 -16.61 -16.05 -16.60 -10.79 -4.10 -15.94 -19.34 -9.89 Adjustment 10.24 10.31 6.46 10.67 3.45 8.84 0.22 2.76 15.56 10.05 Changes in Working Capital -17.23 13.71 9.12 -2.33 -1.38 -39.28 54.65 12.37 19.82 1.61 Cash after chg. in Working capital -35.86 3.90 -1.02 -7.71 -14.53 -41.23 50.76 -0.81 16.04 1.78 Interest Paid 0.00 0.00 -5.17 -3.49 -0.74 -4.03 -1.53 -0.63 -8.66 -7.47 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.11 -0.06 1.07 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -9.05 -4.32 -2.77 -4.70 -4.00 -2.92 0.07 5.54 -1.20 3.76 Net Fixed Assets -9.41 -4.65 -3.19 -6.27 -49.48 -2.92 0.06 -0.61 -3.95 -8.25 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.36 0.33 0.42 1.57 45.48 0.00 0.01 6.15 2.75 12.01 Cash from Financing Activity 27.76 17.32 9.26 15.75 13.22 54.13 -49.28 -4.09 -6.06 0.72 Net Cash Inflow / Outflow -17.14 16.90 0.30 -0.15 -6.04 5.95 0.03 -0.10 0.07 -0.14 Opening Cash & Equivalents 17.32 0.42 0.12 0.27 6.31 0.36 0.33 0.43 0.37 0.51 Closing Cash & Equivalent 0.17 17.32 0.42 0.12 0.27 6.31 0.36 0.33 0.43 0.37

Financial Ratios

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11
Book Value (Rs.) -18.14 -8.59 -12.49 1.04 6.91 -4.63 3.66 8.07 23.50 41.93 ROA -20.91% -14.92% -14.38% -13.46% -14.60% -6.44% -3.19% -10.72% -11.46% -4.25% ROE 0.00% 0.00% 0.00% -296.70% -683.34% 0.00% -75.26% -97.77% -55.86% -16.65% ROCE -56.95% -35.41% -28.95% -27.13% -25.38% -4.33% -3.91% -14.60% -9.06% -1.86% Fixed Asset Turnover 0.14 0.21 0.15 0.02 0.01 0.00 0.00 0.07 0.47 0.49 Receivable days 17.00 12.36 10.34 83.55 51.87 0.00 0.00 130.58 50.71 97.10 Inventory Days 130.87 79.07 92.84 573.34 1435.63 0.00 0.00 925.22 143.77 137.01 Payable days 149.00 123.16 120.44 290.43 338.13 1500.06 2505.25 277.77 107.23 85.09 Cash Conversion Cycle -1.13 -31.73 -17.27 366.46 1149.37 -1500.06 -2505.25 778.03 87.24 149.02 Total Debt/Equity -2.03 -3.74 -3.16 32.19 3.27 -13.34 25.86 11.65 3.72 2.19 Interest Cover -3.81 -2.18 -2.45 -3.60 -21.09 -0.95 -45.92 -24.33 -1.23 -0.32

Top Investors:

sun pharmaceutical industries ltd

brescon ventures private limited

shaaji palliyath

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback